PET and Clinical Changes in Diagnosis
Jul 18, 2018
A prospective cohort study of patients offered amyloid PET as part of their dementia work-up. The results here.
Recent Content
Estrogen, Migraines, and Men
Jul 16, 2018
New research found elevated estrogen levels in nonobese men with migraine and provides evidence of lower levels of testosterone in men with migraine versus men without migraine.
Cerebral Venous Sinus Thrombosis: An Uncommon Etiology of Stroke
Jul 11, 2018
Cerebral venous sinus thrombosis (CVST) accounts for ~1% of cases of stroke. More common in women, CVST is of particular interest because pregnancy and the puerperal period place women at increased risk.
Can Neurologists Identify Patient Suicide Warnings?
Jul 10, 2018
Given that suicide is increasing as a public health concern, better identification of warning signs could assist in directing preventative strategies to the right people.
Sports and Headaches: A Risky Business Quiz
Jul 6, 2018
Which sports-related migraine is associated with longer recovery time, as well as cognitive, neurobehavioral, and somatic symptoms? Test your skills in this quiz.
Predictors of Successful Detox in Medication Overuse Headache
Jul 5, 2018
Some studies have suggested that patients with medication overuse headache may be among the most disabled of headache patients. What are the options for self-detoxification?
Effects of Bioavailable Curcumin on Age-Related Cognitive Symptoms
Jul 5, 2018
A limitation of many supplements is that they are poorly absorbed into the bloodstream after ingestion. A new study used a form of curcumin that had high bioavailability to test its effectiveness in protecting cognition.
Neurology Comic: Stress Test
Jun 29, 2018
We're trying to make our stress tests more realistic.
Does Exercise Improve Cognition in Patients With Dementia?
Jun 29, 2018
The aim of a randomized controlled trial was to see if aerobic and strength training can successfully slow cognitive decline. The results might surprise you.
High Co-prescription of Opioid-SSRI/SNRIs, Despite the Risks
Jun 27, 2018
The combined use of opioids for migraine and triptans or SSRIs/SNRIs for depression can result in serotonin syndrome, which produces symptoms that range from mild to severe to potentially life-threatening.
